Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_assertion type Assertion NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_head.
- NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_assertion description "[CCK/gastrin analogs may be a useful new class of receptor-binding peptides for diagnosis and therapy of CCK-B receptor-expressing tumors, such as MTC or small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_provenance.
- NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_assertion evidence source_evidence_literature NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_provenance.
- NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_assertion SIO_000772 10452322 NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_provenance.
- NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_assertion wasDerivedFrom befree-20140225 NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_provenance.
- NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_assertion wasGeneratedBy ECO_0000203 NP504779.RAlALca41nZdQSr0POuGs4p4KiqYEjI2CGt_H9kzPgKBI130_provenance.